The Global Arteriovenous Malformation Market is undergoing trends in detection by advanced diagnostic techniques

Arteriovenous malformation (AVM) refers to an abnormal connection between the arteries and veins, bypassing the capillaries. This malformation can occur in the brain or other parts of the body, leading to risks such as hemorrhage or blockages. Detection and treatment of AVM helps prevent potential complications. Advanced diagnostic tools like MRI, CT scan, and angiography enable detection of AVM even if asymptomatic, facilitating early clinical management. .
The arteriovenous malformations market is estimated to be valued at USD 3.14 Bn in 2024 and is expected to reach USD 4.99 Bn by 2031, growing at a compound annual growth rate (CAGR) of 6.8% from 2024 to 2031.
Key Takeaways
Key players operating in the Arteriovenous Malformation are Medtronic, Stryker, Terumo Corporation, Johnson & Johnson, and Penumbra.
The growing incidence of AVM and rising demand for minimally invasive treatments are fueling market growth. Significant technological advancements in diagnostic modalities and interventional techniques are further supporting the market expansion.
Globally, there is an increase in healthcare expenditure and access to advanced treatment options. Further, favorable government initiatives are boosting international collaboration and capacity building programs. This is aiding the global expansion of the Arteriovenous Malformation Market.
Market key trends
One of the major trends witnessed in the global arteriovenous malformation market is the rise of intracranial volumetric arterial flow measurement techniques. These novel techniques enable precise computation of blood flow rates and directionality in cerebral vascular malformations. Intra-arterial navigation and 3D volume rendering provide accurate hemodynamic data, guiding clinical decisions for complex AVMs. The technology significantly improves treatment planning and outcomes.
Porter's Analysis
Threat of new entrants: High capital requirement and risk of surgery deter new entrants.
Bargaining power of buyers: Buyers have limited bargaining power as the treatment options are limited and health conditions are critical.
Bargaining power of suppliers: Suppliers have significant bargaining power as there are only a few major service providers and healthcare systems.
Threat of new substitutes: No viable substitutes for treating AVM currently exist thanks to its complex nature requiring specialized equipment and skills.
Competitive rivalry: Competition is intense among the few major players given large treatment costs and specialized skills required.
The United States accounts for over 40% of the global market value for arteriovenous malformation treatment due to high healthcare spending and advanced treatment options. procedures. Key service providers in the US can treat a large patient pool and invest significantly in research.
China is expected to register the fastest market growth during the forecast period. This is attributed to factors such as rising healthcare expenditure, growing medical tourism, and increasing public awareness about AVM. Several international players are entering partnerships with local hospitals in major Chinese cities to tap into the market potential.
Geographical Regions
The United States accounts for over 40% of the global market value for arteriovenous malformation treatment due to high healthcare spending and advanced treatment options. procedures. Key service providers in the US can treat a large patient pool and invest significantly in research.
China is expected to register the fastest market growth during the forecast period. This is attributed to factors such as rising healthcare expenditure, growing medical tourism, and increasing public awareness about AVM. Several international players are entering partnerships with local hospitals in major Chinese cities to tap into the market potential.
About Author:
Ravina Pandya, Content Writer, has a strong foothold in the market research industry. She specializes in writing well-researched articles from different industries, including food and beverages, information and technology, healthcare, chemical and materials, etc.